Manipal Hospitals
| Índia | Turquia | Áustria | |
| Transplante de medula óssea | de $15,000 | de $36,000 | de $140,000 |
| Transplante autólogo de medula óssea | de $11,000 | de $31,500 | de $50,000 |
| Transplante alogénico de medula óssea de dador relacionado | de $20,500 | de $65,000 | de $150,000 |
| Transplante alogénico de medula óssea de dador não relacionado | de $28,000 | de $80,000 | de $180,000 |
| Quimioterapia para cancro da mama | de $3,500 | de $1,200 | de $15,000 |
A Bookimed não adiciona taxas extras aos preços de tratamento de Leucemia linfoblástica aguda. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Leucemia linfoblástica aguda e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Leucemia linfoblástica aguda.
Hematologista-oncologista pediátrica e especialista em transplante de medula óssea no Global Hospital Mumbai.
O Dr. Gaurav Kharya é um especialista em hematologia-oncologia pediátrica e médico de transplante de medula óssea nos Hospitais Artemis.
O Dr. Girish Badarkhe é especialista em leucemia e transplantes de medula óssea, com mais de 13 anos de experiência focada no HCG Manavata Cancer Centre.
Pediatric centers in India report five-year survival rates between 80% and 90% for Acute Lymphoblastic Leukemia. Approximately 90% of children achieve complete remission after first-line chemotherapy. Adult survival rates typically range from 36% to 54%, with younger adults reaching up to 65% at advanced facilities.
Bookimed Expert Insight: Success in India strongly correlates with institutional volume and specialized expertise. Dr. Rahul Bhargava at Fortis Memorial Research Institute has completed over 1,000 transplants. Large networks like Apollo or Manipal serve millions of patients annually. This high volume allows these hospitals to maintain lower infection-related risks during intensive chemotherapy phases.
Patient Consensus: Patients note that pediatric cases are more curable when treated promptly at large tertiary hospitals. Families emphasize that consistent infection management and uninterrupted chemotherapy cycles are the most critical factors for long-term survival.
Top hospitals for Acute Lymphoblastic Leukemia (ALL) in India include Apollo Hospital Indraprastha, Medanta Hospital, and Fortis Memorial Research Institute. These facilities hold JCI or NABH accreditations. Leading oncologists such as Dr. Rahul Bhargava and Dr. Gaurav Kharya specialize in advanced bone marrow transplants.
Bookimed Expert Insight: While many choose Delhi or Mumbai for leukemia care, Bengaluru has emerged as a high-volume hub with centers like Manipal Hospitals serving 2,000,000 patients annually. This massive scale often translates to highly efficient diagnostic loops. Facilities here like Aster CMI integrate niche technology like 3D printing and robotic surgery for complex oncology cases that standard clinics cannot handle.
Patient Consensus: Patients note it is critical to select a large tertiary center that houses its own blood bank and specialized pediatric ICU. They emphasize finding doctors who specialize specifically in hematologic malignancies like leukemia rather than general surgeons who treat solid tumors.
Standard protocols for acute lymphoblastic leukemia (ALL) follow a structured 2–3 year regimen. Indian oncology centers prioritize immediate remission induction. This intensive first phase uses multi-agent chemotherapy. Treatment then transitions into consolidation and long-term maintenance. High-risk cases may require a bone marrow transplant.
Bookimed Expert Insight: Indian clinics like Fortis and Apollo offer rapid transitions to bone marrow transplant (BMT) if induction fails. Dr. Rahul Bhargava at Fortis has completed over 1,000 transplants. This high volume allows clinics to manage complex cases that do not respond to standard 2-year drug protocols.
Patient Consensus: Patients emphasize the importance of constant blood count monitoring. Many note that supportive care for managing nausea and infections is as critical as the chemotherapy itself.
Bone marrow transplant is not an automatic requirement for acute lymphoblastic leukemia. Doctors primarily reserve this procedure for high-risk cases or relapses. Standard treatment often focuses on chemotherapy first. Decisions depend on genetic findings and how the disease responds to initial induction therapy.
Bookimed Expert Insight: India hosts over 90 specialized clinics, including Apollo Hospital Indraprastha, noted as a major global transplant hub. Our data shows experienced specialists like Dr. Rahul Bhargava have performed over 1,000 successful stem cell procedures. This high volume allows Indian centers to maintain low-cost centers. These facilities often facilitate complex cases that require specifically matched related or unrelated donors.
Patient Consensus: Patients note that confusion often exists between diagnostic bone marrow biopsies and the actual transplant procedure. Families emphasize the importance of confirming if chemotherapy has achieved a negative MRD status before committing to a transplant.
Supportive care for acute lymphoblastic leukemia in India integrates advanced medical interventions with psychological and social assistance. Treatment focuses on symptom management, intensive monitoring, and infection prevention through JCI-accredited facilities. Specialized hematology units provide rapid administration of blood components, targeted anti-nausea medication, and clinical nutrition programs.
Bookimed Expert Insight: Indian tertiary centers like Global Hospital Chennai and Apollo Hospital Indraprastha prioritize massive infrastructure for supportive care. Our data shows these facilities maintain 140+ ICU beds and specialized blood banks. This scale is vital for leukemia patients who require frequent, immediate transfusions. Choosing a high-volume center ensures these life-saving resources are always available without delay.
Patient Consensus: Patients emphasize that frequent blood and platelet transfusions are the most critical support measures. They also note that success depends on strict hand hygiene and isolation-like practices to prevent fevers.